AITRICS, a medical AI startup, secured $20.1 million in a Series B funding round, with existing and new investors participating. The company’s flagship software, Vital Care, uses AI to predict patient deterioration by analyzing various medical data. AITRICS plans to use the funds to obtain FDA clearance and expand internationally. The company has partnerships with various hospitals in South Korea and is involved in research collaborations to improve medical services. AITRICS also has a partnership with Philips Korea to develop AI-based solutions for intensive care units. The funding round reflects the growing interest in AI-driven medical technologies, with similar companies like Cytovale also raising significant funds.
Source link
Korean startup AITRICS seeks US entry with latest $20M funding
